¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Observation for suspected toxic effect from ingested substance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® adverse effect ÇÑ±Û ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
¼³¸í   
  ¾à¹°¿¡ ÀÇÇÑ Ä¡·á¸¦ ÇÒ ¶§ ³ªÅ¸³ª´Â Ä¡·á¸ñÀû¿¡ ºÎÇÕµÇÁö ¾Ê´Â ºÒÄèÇÑ ÀÛ¿ë, Áï ºÎÀÛ¿ëÀ» ¿ªÈ¿°ú·Î Ç¥ÇöÇϴ °æ¿ì°¡ ÀÖ´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡¼­´Â ¿ªÈ¿°ú¶õ ¡°¿¹¹æ, Áø´Ü, Ä¡·áÀÇ ¸ñÀûÀ¸·Î »ç¶÷¿¡°Ô »ó¿ë·®ÀÇ ¾àÀ» »ç¿ëÇÏ¿´À» ¶§ ¹ßÇöÇϴ Àå¾Ö·Î, ÀǵµÇÏÁö ¾ÊÀº Àۿ롱À̶ó°í Á¤ÀÇÇϰí ÀÖ´Ù. ¾à¹°¿¡ ÀÇÇÑ Ä¡·á¸¦ ÇÒ ¶§, Æ¯È÷ ÁÖ¸ñÇÏ¿©¾ß ÇÒ ÀϹÝÀûÀΠ¿ªÈ¿°ú·Î¼­ ¾à¹°¾Ë·¹¸£±â, Á¶Ç÷Àå±â Àå¾Ö, °£-ÄáÆÏÀÇ Àå¾Ö, ¹°Áú ´ë»ç Àå¾Ö µîÀÌ ÀÖ´Ù. ÀÌ ¿Ü¿¡ ÀÓ»êºÎ¿¡°Ô Åõ¿©ÇÏ¿© ¹ß»ýÇÑ ±âÇü¹ß»ý, ¸¶¾à, °¢¼ºÁ¦, ±âŸ ÇâÁ¤½ÅÁ¦¿¡ ÀÇÇÑ ÀÇÁ¸¼º Çü¼ºµµ Áß¿äÇÏ´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • behavioral observation audiometry
    Çൿ°üÂûû·Â°Ë»ç
  • naturally toxic plant
    ÀÚ¿¬µ¶¼º½Ä¹°
  • observation
    °üÂû
  • potentially toxic compound
    ÀáÀçµ¶¼º¹°Áú
  • streptococcal toxic shock syndrome
    »ç½½¾Ë±Õµ¶¼º¼îÅ©ÁõÈıº, ¿¬¼â±¸±Õµ¶¼º¼îÅ©ÁõÈıº
  • self-observation
    ÀÚ±â°üÂû
  • antibacterial substance
    Ç×±Õ¹°Áú
  • antifungal substance
    Ç×Áø±Õ¹°Áú
  • carcinogenic substance
    ¹ß¾Ï¹°Áú
  • cortical substance
    °ÑÁú, ÇÇÁú
  • crystalline substance
    °áÁ¤¹°Áú
  • cement substance
    Á¢ÇÕÁú, ½Ã¸àÆ®¹°Áú
  • chromophil substance
    È£»ö¼Òü, »ö¼Òģȭ¹°Áú
  • depressor substance
    °¨¾Ð¹°Áú
  • ferromagnetic substance
    °­ÀÚ¼º¹°Áú
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • toxic substance
    µ¶¼º¹°Áú
  • observation
    °üÂû
  • self-observation
    ÀÚ±â°üÂû
  • toxic agent
    µ¶¹°, µ¶±Ø¹°
  • toxic erythema
    Áßµ¶È«¹Ý
  • toxic nodule
    µ¶¼º°áÀý
  • toxic epidermal necrolysis
    µ¶¼ºÇ¥ÇDZ«»ç¿ëÇØ
  • substance
    ¹°Áú, Áú
  • antibacterial substance
    Ç×±Õ¹°Áú
  • inhibitor substance
    ¾ïÁ¦¹°Áú
  • intercellular substance
    ¼¼Æ÷»çÀ̹°Áú
  • odoriferous substance
    Çâ·á
  • pyrogenic substance
    ¹ß¿­¹°Áú
  • reaction substance
    ¹ÝÀÀ¹°Áú
  • reserve substance
    ÀúÀå¹°Áú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • behavioral observation audiometry
    Çൿ°üÂûû·Â°Ë»ç
  • self-observation
    ÀÚ±â°üÂû
  • toxic substance
    µ¶¼º¹°Áú
  • toxic effect
    Áßµ¶È¿°ú, Áßµ¶ÀÛ¿ë
  • toxic agent
    µ¶¹°, µ¶±Ø¹°
  • toxic alopecia
    µ¶¼ºÅ»¸ðÁõ
  • toxic amaurosis
    Áßµ¶Èæ¾Ï½Ã
  • toxic amblyopia
    µ¶¼º¾à½Ã
  • toxic atrophy
    Áßµ¶À§Ãà
  • potentially toxic compound
    ÀáÀçµ¶¼º¹°Áú
  • toxic cardiopathy
    Áßµ¶½ÉÀ庴Áõ
  • toxic cataract
    Áßµ¶¹é³»Àå
  • toxic conjunctivitis
    µ¶¼º°á¸·¿°
  • toxic convulsion
    Áßµ¶°æ·Ã
  • toxic liver cirrhosis
    µ¶¼º°£°æÈ­(Áõ)
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • health observation
    °Ç°­°üÂû(ÊÙ˴̤).
  • psychosis, toxic
    µ¶¹°Á¤½Åº´, Áßµ¶Á¤½Åº´.
  • ground substance amorphous substance
    ¹«ÇüÁú
  • C-substance
    C-¹°Áú.
  • EPS=£¾exophthalmos producing substance
    ¾È±¸µ¹ÃâÀ¯¹ß¹°Áú.
  • Goitrogenic substance
    °©»ó¼±Á¾À¯¹ß¹°Áú(Ë£ßÒàÍðþë¯Û¡Úªòõ)
  • Inducer substance
    À¯µµ¹°Áú(ë¯ÓôÚªòõ)
  • Inhibitor substance
    ¾ïÁ¦¹°Áú(åäð¤Úªòõ)
  • Kerry reducing substance test
    Äɸ®È¯¿ø¹°Áú½ÃÇè
  • Mullerian inhibiting substance
    ¹°·¯°ü ¾ïÁ¦¹°Áú
  • P substance
    P¹°Áú
  • SRS A : slow reacting substance A
    ¿¡½º¾Ë¿¡½º-¿¡ÀÌ.
  • accelerans substance
    ÃËÁø¹°Áú(õµòäÚªòõ).
  • accessory food substance
    ºÎ¿µ¾ç¹°(Üùç½å×Úª).
  • acrosomal substance
    ÷´Üü¹°Áú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • audiometry, behavioral observation
    Çൿ°üÂûû·Â°Ë»ç
  • behavioral observation audiometry
    Çൿ°üÂûû·Â°Ë»ç
  • health observation
    °Ç°­°üÂû(ÊÙ˴̤).
  • observation hip
    °üÂû¼º °í(κóÌàõÍÆ), °üÂû °í(κóÌÍÆ).
  • self-observation
    ÀÚ±â°üÂû
  • toxic substance
    À¯µ¶¼ººÐ(êóÔ¸à÷ÝÂ), µ¶¹°(Ô¸Úª), µ¶¼º¹°Áú.
  • ground substance amorphous substance
    ¹«ÇüÁú
  • toxic effect
    Áßµ¶È¿°ú(¡­üùÍý).
  • toxic effect
    µ¶¼ºÈ¿°ú
  • toxic effect curve
    µ¶¼º°î¼±(Ô¸àõÍØàÊ).
  • diffuse toxic goiter
    ¹ü¹ß¼º Áßµ¶¼º °©»ó¼±Á¾(ÛñÛ¡àõñéÔ¸àõË£ßÒàÍðþ).
  • effluvium, toxic<³ª>
    µ¶¼ºÅ»¸ð.
  • minimum toxic dose
    ÃÖ¼ÒÁßµ¶·®(õÌá³ñéÔ¸åÖ).
  • minimum toxic dose
    ÃÖ¼ÒÁßµ¶·®(̧ËÛÌ¡ËÄËâ).
  • naturally toxic plant
    ÀÚ¿¬µ¶¼º½Ä¹°(~ËÄËÛËàËÑ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Ground substance [Amorphous substance]
    ¹«ÇüÁú
    [¿¾ ¿ë¾î] ±âÁú
  • Lateral intermediate substance
    °¡ÂÊÁß°£È¸»öÁú
    [¿¾ ¿ë¾î] Áß°£Áú¿ÜÃøºÎ
  • Proper substance of cornea
    °¢¸·°íÀ¯Áú
    [¿¾ ¿ë¾î] °¢¸·°íÀ¯Áú
  • Proper substance of sclera
    °ø¸·°íÀ¯Áú
    [¿¾ ¿ë¾î] °ø¸·°íÀ¯Áú
  • Muscular substance
    ±ÙÀ°Áú
    [¿¾ ¿ë¾î] ±ÙÁú
  • Chromophilic substance [Nissl body]
    ´Ö½½¼Òü
    [¿¾ ¿ë¾î] ´Ö½½¼Òü
  • Posterior perforated substance
    µÚ°üÅëÁú
    [¿¾ ¿ë¾î] ÈÄÀ¯°øÁú
  • Fundamental substance
    ¹«ÇüÁú
    [¿¾ ¿ë¾î] ±âÁú
  • Fundamental substance
    ¹«ÇüÁú
    [¿¾ ¿ë¾î] »ó¾ÆÁú±âÁú
  • Fundamental substance
    ¹«ÇüÁú
    [¿¾ ¿ë¾î] ¿¬°ñ±âÁú
  • White substance
    ¹é»öÁú
    [¿¾ ¿ë¾î] ¹éÁú
  • Cortical substance
    »À°ÑÁú
    [¿¾ ¿ë¾î] ÇÇÁú
  • Fibrinoid substance
    ¼¶À¯¼Ò¼º¹°Áú
    [¿¾ ¿ë¾î] À¯¼¶À¯¼ÒÁú
  • Reticular substance
    ¼¼¸ÁÁú
    [¿¾ ¿ë¾î] ¼¼¸ÁÁú
  • Intercellular substance
    ¼¼Æ÷»çÀ̹°Áú
    [¿¾ ¿ë¾î] ¼¼Æ÷°£Áú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • median toxic dose
    Á¤Áß µ¶¼º·®(ïáñéÔ¸àõÕá)
  • C substance
    C ¹°Áú(Úªòõ)
  • ferredoxin reducing substance
    Æä¸®µ¶½Å ȯ¿ø ¹°Áú(ü½êªÚªòõ)
  • ground substance
    ¹ÙÅÁ¹°Áú(Úªòõ)
  • pectic substance
    Æåƾ ¹°Áú(Úªòõ)
  • photodynamic substance
    ±¤¿ªÇÐ ¹°Áú(Úªòõ)
  • queen substance
    ¿©¿ÕºÀ(Ò³èÝÜð) ¹°Áú(Úªòõ)
  • rabbit aorta contracting substance
    Åä³¢ ´ëµ¿¸Æ ¼öÃ๰Áú(ÓÞÔÑØæâ¥õêÚªòõ)
  • slow-reacting substance
    ¿Ï¼Ó(èÐáÜ) ¹ÝÀÀ¹°(ÚãëëÚª)
  • substance P
    P ¹°Áú(Úªòõ)
  • threshold substance
    ¹®Åι°Áú(Úªòõ)
  • anomeric effect
    ¾Æ³ë¸Ó¿µÇâ(ç¯úÂ)
  • asymmetry effect
    ºÎÀçÈ¿°ú(Üôî²üùÍý)
  • Blinks effect
    ºí¸°Å©½º È¿°ú(üùÍý) (ÔÒ) chromatic transient
  • Bohr effect
    º¸¾î È¿°ú(üùÍý)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nodular toxic goiter
    °áÀý¼ºÁßµ¶¼º°©»ó¼±Á¾
  • toxic
    µ¶¼ºÀÇ
  • anterior perforated substance
    ÀüÀ¯°ø¹°Áú
  • ferromagnetic substance
    öÀÚ¼ºÃ¼, °­ÀÚ¼ºÃ¼
  • gray substance
    ȸ»öÁú
  • nerve transmitter substance
    ½Å°æÀü´Þ¹°Áú
  • paramagnetic substance
    »óÀÚ¼º¹°Áú
  • radioactive substance
    ¹æ»ç¼º¹°Áú
  • substance
    ¹°Áú
  • adverse effect
    ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
  • air gap effect
    °ø±â°£°ÝÈ¿°ú
  • Bernouilli effect
    º£¸£´©ÀÌÈ¿°ú
  • biologic effect
    »ý¹°ÇÐÀûÈ¿°ú
  • biological effect
    »ý¹°ÇÐÀûÈ¿°ú
  • cavitation effect
    °øµ¿È¿°ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SATS substance, amount ingested, time ingested, symptoms
TS Takayasu syndrome; Tay-Sachs; temperature sensitivity; temperature, skin; temporal stem; tensile str...
SADR suspected adverse drug reaction
SCAN suspected child abuse and neglect; systolic coronary artery narrowing
MIS management information system; medical information service; meiosis-inducing substance; minimally in...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TSCA Toxic Substance Control Act
HOME Home Observation for Measurement of the Environment
LOCF Last Observation Carried Forward
NOSIE Nurse's Observation Scale for Inpatient Evaluation
PYO person years of observation
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • Z03.6
    Observation for suspected toxic effect from ingested substance
    ÀǽɵǴ ¼·ÃëÇÑ ¹°ÁúÀÇ Áßµ¶¿µÇâÀÇ °üÂû
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • toxic substance
    À¯µ¶ ¼ººÐ, µ¶¹°
  • toxic effect curve
    µ¶¼º °î¼±
  • health observation
    °Ç°­ °üÂû
  • observation
    °üÂû
    ÁÖÀDZí°Ô º¸°Å³ª ÁÖÀǸ¦ ±â¿ïÀÌ´Â Çൿ ¶Ç´Â ´É·Â. ¾î¶² °ÍÀ» º¸°Å³ª ¸¶À½À» °Å±â¿¡ µÎ´Â °Í. ÀûÀýÇÑ ±â±¸¸¦ °¡Áö°í Å©±â¸¦ ÃøÁ¤Çϰųª ÀÎÁöÇÏ´Â Çൿ.
  • allergic-toxic contact stomatitis
    ¾Ë·¯Áö-µ¶¼º Á¢ÃË ±¸³»¿°
  • nodular toxic goiter
    °áÀý¼º Áßµ¶¼º °©»ó¼±Á¾
  • toxic action
    µ¶ ÀÛ¿ë
  • toxic amblyopia
    Áßµ¶ ¾à½Ã
  • toxic damage
    µ¶¼º ¼Õ»ó
  • toxic dyspepsia
    Áßµ¶¼º ¼ÒÈ­ ºÒ·®
  • toxic fume bronchiolitis obliterans
    µ¶¼º ¿¬±â¿¡ ÀÇÇÑ Æó¼â¼º ¼¼±â°üÁö¿°
    Áú¼Ò »êÈ­¹°, Æ÷½º°ÕÀ̳ª ±âŸ À¯µ¶ °¡½º¿¡ Æø·ÎµÈ ÈÄ 1-3ÁÖ ÈÄ ¹ß»ýÇÑ´Ù. ÈäºÎ ¹æ»ç¼± »çÁø»ó ¹Ì¸¸¼º ƯÀ̼º ÆóÆ÷ ¶Ç´Â °£À¯¸® À½¿µÀ» º¸ÀδÙ.
  • toxic mucosal damage
    µ¶¼º Á¡¸· ¼Õ»ó
  • toxic myocarditis
    Áßµ¶¼º ½É±Ù¿°
  • toxic reaction
    µ¶ ¹ÝÀÀ, Áßµ¶ ¹ÝÀÀ
  • toxic uninodular goiter
    Áßµ¶¼º ´Ü°áÀý¼º °©»ó¼±Á¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
toxic effect <physiology> The physiologic, physical or laboratory manifestations or derangement that can be attributed to the presence of a substance within the body.
(12 Jan 1998)
conoscopic observation <microscopy> The study of the back focal plane of the objective by removing the eyepiece, by inserting a Bertrand lens, by examining the image at the eye point above the eyepiece with a magnifier or by using a phase telescope is called conoscopic because the observations are associated with the cone of light furnished by the condenser and viewed by the objective (cf. Orthoscopic).
(05 Aug 1998)
observation An act or the faculty of observing or taking notice: an act of seeing or fixing the mind upon something, an act of recognising and noting measurement of some magnitude with suitable instruments.
(18 Nov 1997)
orthoscopic observation <microscopy> The normal way of viewing an object microscopically (cf., conoscopic observation). With Kohler illumination the field diaphragm and the ocular front focal plane as well as the specimen will be in simultaneous focus.
(05 Aug 1998)
megacolon, toxic Acute dilatation of the colon associated with amebic or ulcerative colitis. The dilatation may precede perforation of the colon.
(12 Dec 1998)
goiter, diffuse toxic Graves' disease, the most common cause of hyperthroidism, too much thyroid hormone.
(12 Dec 1998)
goiter, toxic multinodular Condition in which the thyroid gland contains multiple lumps (nodules) that are overactive and produce excess thyroid hormones. This condition is also known as Parry's disease or Plummer's disease.
(12 Dec 1998)
plants, toxic Plants or plant parts which are harmful to man or other animals.
(12 Dec 1998)
hepatitis, toxic Acute hepatitis caused by true hepatotoxins such as amanita phaloides toxin, carbon tetrachloride, yellow phosphorus, and a variety of drugs.
(12 Dec 1998)
shock, toxic See Syndrome, toxic shock.
(12 Dec 1998)
syndrome, toxic shock A grave condition occurring predominantly in menstruating women using tampons, toxic shock is characterised by a highly toxic state (with sudden high fever, vomiting, diarrhoea, muscle aching) followed by low blood pressure (hypotension) which can lead to shock (and death). There may be a rash resembling sunburn with peeling of skin. The channing laboratory in boston under dr. Edw. Kass discovered that toxic shock was due to a toxin produced by staph (staphylococcus) aureus bacteria growing under conditions with little or no oxygen. The syndrome occurs rarely in women not using tampons and in men.
(12 Dec 1998)
drugs toxic to lung <radiology> Bleomycin, methotrexate, cytoxan, amiodarone
(12 Dec 1998)
toxic Pertaining to, due to or of the nature of a poison or toxin, manifesting the symptoms of severe infection.
(18 Nov 1997)
toxic amaurosis Blindness due to optic neuritis caused by methyl alcohol, lead, arsenic, quinine, or other poisons.
(05 Mar 2000)
toxic amblyopia Blindness due to optic neuritis caused by methyl alcohol, lead, arsenic, quinine, or other poisons.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • toxic
    À¯µ¶ÇÑ
  • toxic
    (Áß)µ¶ÀÇ
  • observation
    °üÂû(·Â);ÁÖ¸ñ;°¨½Ã;°üÂû°á°ú;¼Ò°ß;~al a
  • observation car
    Àü¸ÁÂ÷
  • observation post
    °üÃø¼Ò
  • participant observation
    Âü¿©Àû °üÂû(¹ý)
  • in substance
    »ç½Ç»ó,½ÇÁúÀûÀ¸·Î
  • substance
    ¹°Áú,½Çü,º»Ã¼,º»Áú,³»¿ë,¾Ë¸ÍÀÌ,¼ºÁú,Àç»ê,ÀÚ»ê
  • the substance
    ´ëºÎºÐ
  • controlled substance
    ±ÔÁ¦ ¾à¹°(¼ÒÁö¹× »ç¿ëÀÌ ±ÔÁ¦µÇ´Â ¾à¹°)
  • substance
    ¹°Áú;(¾î¶² Á¾·ùÀÇ)¹°°Ç;½Çü;º»Áú;¿äÁö;½ÇÁú;Àç»ê;in ~ ´ëü·Î;½ÇÁúÀûÀ¸·Î;»ç½Ç»ó
  • effect
    °á°ú,¿µÇâ,È¿°ú,½Ç½Ã,ÃÊ·¡ÇÏ´Ù
  • side effect
    ºÎÀÛ¿ë
  • Compton effect
    ÄÞÇÁÅÏ È¿°ú(±¤ÀÚ¿Í ÀüÀÚÀÇ Åº¼º »ê¶õ)
  • Donald Duck effect
    µµ³Îµå ´ö È¿°ú(¿ìÁÖ ºñÇàÁßÀÇ À½¼ºÀÇ °íÀ½È­ Çö»ó)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á